Literature DB >> 9863933

Botulinum toxin injections for voiding dysfunction following SCI.

J S Wheeler1, J S Walter, R S Chintam, S Rao.   

Abstract

Botulinum toxin (BT) injections have been used successfully to treat spastic muscle conditions, including detrusor-sphincter dyssynergia (DSD) seen in spinal cord injury (SCI) patients. In our urology clinic, we used BT to treat three SCI patients who had voiding dysfunction, using a transperineal needle with electromyographic (EMG) monitoring. Two of the patients reported excellent results following the treatment. One patient, with whom the staff had difficulty doing intermittent catheterization (IC), improved significantly. The other patient had improved voiding with an external catheter and minimal urinary residual. The third patient had no improvement of leg spasms with his voiding dysfunction and required a sphincterotomy. Although patients may need repeat injections, BT is minimally invasive and easy to administer with no side effects. Overall, BT injection is an excellent method of managing voiding in SCI patients, especially those on continuous external catheters and with IC management who refuse or are not good candidates for surgery.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9863933     DOI: 10.1080/10790268.1998.11719531

Source DB:  PubMed          Journal:  J Spinal Cord Med        ISSN: 1079-0268            Impact factor:   1.985


  4 in total

Review 1.  Botox in urology.

Authors:  Ali Thwaini; Iqbal Shergill; Suresh Radhakrishnan; Frank Chinegwundoh; Hadeel Thwaini
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2005-11-19

2.  Bladder management for adults with spinal cord injury: a clinical practice guideline for health-care providers.

Authors: 
Journal:  J Spinal Cord Med       Date:  2006       Impact factor: 1.985

Review 3.  [Botulinum toxin in urology. An inventory].

Authors:  H Schulte-Baukloh; H H Knispel
Journal:  Urologe A       Date:  2004-08       Impact factor: 0.639

Review 4.  Use of botulinum toxin for voiding dysfunction.

Authors:  David Eldred-Evans; Prokar Dasgupta
Journal:  Transl Androl Urol       Date:  2017-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.